Skip to main content
. 2015 May 7;10(5):e0125343. doi: 10.1371/journal.pone.0125343

Fig 7. Higher JARID1B expression is associated with higher stem cell-like characteristics in NB cells and poor prognosis in NB patients.

Fig 7

(A) ALDH activity, (B) SP proportion and (C) CD133-ALDH double positivity is suppressed in JARID1B-shRNA infected cells, compared to JARID1B-expressing control cells. (D) Higher JARID1B expression is associated with poor prognosis in NB patients. A web-based software package, R2: microarray analysis and visualization platform (http://r2.amc.nl), consisting of 88 NB tumors with age, INSS staging, MYCN status, and survival information was used for this analysis. JARID1B expression is associated with more advanced tumor stage (stage 4 vs. stage 3, p = 7.6x10-5). Using median mRNA level of JARID1B as the cutoff, the relapse-free survival probability of patients with higher JARID1B expression was significantly worse than those with lower expression (p = 0.027).